/data/photo/2020/09/08/5f56feb8f3969.jpg "Corona Vaccine Available in Indonesia Next Month, Expert Said Page all")
KOMPAS.com- Corona vaccine from a number of biotechnology companies from several countries purchased Indonesia, will be distributed soon next month.
Quoted from the news Kompas.com, Monday (12/10/2020), according to a press release from the Ministry of Communications, the government is scheduled to be available in November 2020.
During work visits and bilateral meetings with Foreign Ministers and Government ranks China in Yunan, Coordinating Minister for Maritime Affairs and Investment Luhut Pandjaitan together with Health Minister Terawan Agus Putranto and the group met with three producers corona vaccine, Saturday (10/10/2020).
The three producers, namely CanSino, G42 or Sinopharm and Sinovac, in order to finalize the purchase of vaccines for Covid-19.
Also read: Making Corona Vaccines Threatens the Life of Sharks, How Can?
Program plan Covid-19 vaccination President Joko Widodo has asked to immediately disseminate it to the public. He asked the community to know the details of this program plan, so that it can run smoothly.
So, will some of the corona vaccines currently in phase 3 clinical trials be effective if used next month?
In response to this, member molecular biology Professor Amin Soebandrio said the use of vaccines in conditions such as the current pandemic was possible immediately.
“However, in this case the POM and the Ministry of Health must have given permission. Because the authority lies with these two institutions,” said Prof. Amin when contacted. Kompas.com, Monday (12/10/2020).
Currently, most vaccines are being tested clinically in Indonesia. Some of them are in the process.
The head of the Eijkman Institute for Molecular Biology (LBM) added that as long as the vaccines meet the requirements, it is possible to use them immediately.
Prof. Amin explained that a number of countries issued Emergency Use Authorization (EUA), which is a permit for emergency use of vaccines for Covid-19 due to various considerations.
“If published emergency use Therefore, vaccines can be used with various considerations related to the pandemic situation at hand, “explained Amin.
This is because many people hope that the corona virus vaccine can be used immediately to overcome the current Covid-19 pandemic.
Although he does not know which vaccine will be used in November, Prof. Amin emphasized that it all depends on the authority of BPOM and the Ministry of Health.
Criteria for emergency use of vaccines
Regarding the conditions that must be met so that the Covid-19 vaccination can be carried out immediately, Prof. Amin explained that the vaccine has completed phase 1 and phase 2.
Meanwhile, phase 3 must also be tested like phase 1 and phase two, but with a much larger number of test populations or subjects to prove the effectiveness of the vaccine being developed.
“There are indeed considerations but not necessarily used. For example, clinical trials have been running 50 percent and all show the same results (successful). Nothing has failed. So that can be one of the considerations given. emergency use, “explained Prof. Amin.
Also read: British Scientists Inhaled Corona Vaccine
Nevertheless, Prof. Amin reminded that clinical trials must still be completed, even though the EUA has been published. Or in other conditions, for example a clinical trial that has only been partially carried out, but the results are considered satisfactory.
However, when the situation is urgent and cannot be postponed, emergency use can be carried out. However, Prof. Amin explained that emergency vaccine use is only given to certain populations.
“For certain groups, it cannot be widely used. One country is also implementing this by giving the Covid-19 vaccine on the military, “added Amin.
In the midst of the massive clinical trial of the corona virus vaccine produced abroad on thousands of people in Indonesia, vaccine development domestic is also being done.
Also read: Expert: It is better if the Corona Sinovac Vaccine Test is Conducted in the Red Zone, Why?
Prof. Amin said that the production of a red and white vaccine to fight Covid-19, which is currently being carried out in the Eijkman laboratory, is in the stage of developing vaccine seeds.
“The phase is still in the laboratory phase, but it’s already 55 percent. We are currently waiting for protein secretion,” said Prof. Amin.
Red and white vaccine It is hoped that the phase 1 clinical trial phase can be carried out in the second trimester next year.
“As for all phases of clinical trials Indonesia’s corona vaccine This is expected to be completed by the end of next year (2021), “said Prof. Amin.
– .
